慢性肺炎中的致病细胞:呼吸道重塑的机制,免疫失调和治疗影响
Kailin Zhou1, Qianmei Wen1, Yujie Zuo1
1State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, People's Republic of China.
本综述探讨了慢性阻塞性肺病 (COPD) 所涉及的细胞的病理变化,强调了细胞衰老,代谢重编程和细胞间通信. 了解这些机制为COPD提供了新的治疗目标.
科学领域:
- 肺病学
- 细胞生物学
- 病理学
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及肺细胞的复杂病理变化,包括异常修复,蛋白酶-抗蛋白酶失衡和免疫功能障碍.
- 这些细胞变化导致肺部破坏和呼吸道重塑, 但细胞衰老,代谢重编程和细胞间网络的确切作用尚不清楚.
研究的目的:
- 综合审查近期了解COPD的主要病理细胞的进展.
- 阐明COPD中呼吸道上皮细胞,纤维细胞,内皮细胞和免疫炎症细胞的病理变化,疾病进展影响和临床影响.
主要方法:
- 对COPD细胞病理学的当前研究进行系统审查.
- 对细胞衰老,代谢重编程和细胞间相互作用网络的作用进行分析.
- 研究COPD病变的外体介导miRNA转移.
主要成果:
- 慢性肺炎细胞的病理变化包括异常修复,蛋白酶-抗蛋白酶失衡和免疫障碍,导致肺部破坏和呼吸道重塑.
- 在COPD的发病过程中,关键的细胞参与者包括呼吸道上皮细胞,纤维细胞,内皮细胞和免疫炎症细胞.
- 外体介导的miRNA转移有助于COPD相关的炎症和纤维化.
结论:
- 了解COPD细胞内的病理变化和机制对于疾病管理至关重要.
- 细胞衰老,代谢重编程和细胞间通信是未来COPD研究的重要领域.
- 外体介导的过程为缓解COPD进展提供了潜在的新疗法目标.
更多相关视频
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
